Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Exact Sciences (EXAS) reported a Q4 loss of $0.06 per share, which was better than the expected loss of $0.32 per share. This is an improvement from the $0.27 per share loss a year ago.
February 19, 2025 | 11:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences reported a smaller-than-expected Q4 loss of $0.06 per share, beating the Zacks Consensus Estimate of a $0.32 loss. This marks an improvement from the previous year's $0.27 loss per share.
The better-than-expected earnings report is likely to positively impact EXAS's stock price in the short term. The company not only beat the consensus estimate but also showed improvement from the previous year, which is a positive signal for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100